Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2025-01-14 2025-01-14
Drug Identification Number 02523140 02523140
Brand name CALCIUM GLUCONATE INJECTION, USP 10% CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name CALCIUM GLUCONATE INJECTION, USP 10% CALCIUM GLUCONATE INJECTION, USP 10%
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CALCIUM GLUCONATE CALCIUM GLUCONATE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 500 mL 500 mL
ATC code B05XA B05XA
ATC description
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2025-01-01 2025-01-01
Actual start date 2025-01-01 2025-01-01
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments For questions or concerns contact Baxter customer care (1.888.719.9955) or your local Baxter representative. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local Baxter representative.
Health Canada comments